Sweden · Delayed Price · Currency is SEK Humana AB Statistics
Total Valuation
Humana AB has a market cap or net worth of SEK 2.36 billion. The enterprise value is 6.64 billion.
| Market Cap | 2.36B |
| Enterprise Value | 6.64B |
Important Dates
The next confirmed earnings date is Friday, July 17, 2026.
| Earnings Date | Jul 17, 2026 |
| Ex-Dividend Date | Jun 2, 2026 |
Share Statistics
Humana AB has 47.52 million shares outstanding. The number of shares has decreased by -3.87% in one year.
| Current Share Class | 47.52M |
| Shares Outstanding | 47.52M |
| Shares Change (YoY) | -3.87% |
| Shares Change (QoQ) | -1.68% |
| Owned by Insiders (%) | 2.45% |
| Owned by Institutions (%) | 24.63% |
| Float | 26.59M |
Valuation Ratios
The trailing PE ratio is 12.21 and the forward PE ratio is 8.12.
| PE Ratio | 12.21 |
| Forward PE | 8.12 |
| PS Ratio | 0.24 |
| PB Ratio | 0.72 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 3.58 |
| P/OCF Ratio | 3.28 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 6.39, with an EV/FCF ratio of 10.07.
| EV / Earnings | 33.22 |
| EV / Sales | 0.67 |
| EV / EBITDA | 6.39 |
| EV / EBIT | 14.51 |
| EV / FCF | 10.07 |
Financial Position
The company has a current ratio of 0.65, with a Debt / Equity ratio of 1.33.
| Current Ratio | 0.65 |
| Quick Ratio | 0.59 |
| Debt / Equity | 1.33 |
| Debt / EBITDA | 4.23 |
| Debt / FCF | 6.66 |
| Interest Coverage | 2.08 |
Financial Efficiency
Return on equity (ROE) is 6.14% and return on invested capital (ROIC) is 4.91%.
| Return on Equity (ROE) | 6.14% |
| Return on Assets (ROA) | 2.91% |
| Return on Invested Capital (ROIC) | 4.91% |
| Return on Capital Employed (ROCE) | 6.42% |
| Weighted Average Cost of Capital (WACC) | 4.21% |
| Revenue Per Employee | 610,345 |
| Profits Per Employee | 12,257 |
| Employee Count | 22,000 |
| Asset Turnover | 1.01 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Humana AB has paid 54.00 million in taxes.
| Income Tax | 54.00M |
| Effective Tax Rate | 21.09% |
Stock Price Statistics
The stock price has increased by +33.98% in the last 52 weeks. The beta is 0.08, so Humana AB's price volatility has been lower than the market average.
| Beta (5Y) | 0.08 |
| 52-Week Price Change | +33.98% |
| 50-Day Moving Average | 48.90 |
| 200-Day Moving Average | 46.21 |
| Relative Strength Index (RSI) | 43.97 |
| Average Volume (20 Days) | 109,868 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Humana AB had revenue of SEK 9.96 billion and earned 200.00 million in profits. Earnings per share was 4.07.
| Revenue | 9.96B |
| Gross Profit | 2.13B |
| Operating Income | 458.00M |
| Pretax Income | 256.00M |
| Net Income | 200.00M |
| EBITDA | 553.00M |
| EBIT | 458.00M |
| Earnings Per Share (EPS) | 4.07 |
Balance Sheet
The company has 254.00 million in cash and 4.40 billion in debt, with a net cash position of -4.14 billion or -87.14 per share.
| Cash & Cash Equivalents | 254.00M |
| Total Debt | 4.40B |
| Net Cash | -4.14B |
| Net Cash Per Share | -87.14 |
| Equity (Book Value) | 3.30B |
| Book Value Per Share | 66.45 |
| Working Capital | -821.00M |
Cash Flow
In the last 12 months, operating cash flow was 721.00 million and capital expenditures -61.00 million, giving a free cash flow of 660.00 million.
| Operating Cash Flow | 721.00M |
| Capital Expenditures | -61.00M |
| Depreciation & Amortization | 95.00M |
| Net Borrowing | -862.00M |
| Free Cash Flow | 660.00M |
| FCF Per Share | 13.89 |
Margins
Gross margin is 21.39%, with operating and profit margins of 4.60% and 2.01%.
| Gross Margin | 21.39% |
| Operating Margin | 4.60% |
| Pretax Margin | 2.57% |
| Profit Margin | 2.01% |
| EBITDA Margin | 5.55% |
| EBIT Margin | 4.60% |
| FCF Margin | 6.63% |
Dividends & Yields
This stock pays an annual dividend of 1.35, which amounts to a dividend yield of 2.71%.
| Dividend Per Share | 1.35 |
| Dividend Yield | 2.71% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | 4 |
| Payout Ratio | 25.00% |
| Buyback Yield | 3.87% |
| Shareholder Yield | 6.58% |
| Earnings Yield | 8.46% |
| FCF Yield | 27.92% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Analyst Forecast
The average price target for Humana AB is 62.50, which is 29.40% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | 62.50 |
| Price Target Difference | 29.40% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (3Y) | 3.08% |
| EPS Growth Forecast (3Y) | 22.85% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Humana AB has an Altman Z-Score of 1.6 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.6 |
| Piotroski F-Score | 5 |